BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 037214
(455 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|4BCO|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|D Chain D, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 31.6 bits (70), Expect = 0.94, Method: Compositional matrix adjust.
Identities = 48/229 (20%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 19 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + ++ ++E + E+ K Q++ ME
Sbjct: 79 ------LRGKLQLVGTAAMLLAS-------KFEEIYPPEVAEFVYITDDTYTKKQVLRME 125
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 126 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 179
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIAA+A A + + E++IR+ T Y E L+ CL D
Sbjct: 180 YLPSVIAAAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 223
>pdb|1VYW|B Chain B, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|D Chain D, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|B Chain B, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|D Chain D, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|B Chain B, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|D Chain D, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|B Chain B, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|D Chain D, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|B Chain B, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|D Chain D, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|B Chain B, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|D Chain D, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|B Chain B, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|D Chain D, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|B Chain B, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|D Chain D, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 265
Score = 31.2 bits (69), Expect = 1.3, Method: Compositional matrix adjust.
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 22 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 81
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + + + ++E + E+ K Q++ ME
Sbjct: 82 ------LRGKLQLVGTAAMLL-------ASKFEEIYPPEVAEFVYITDDTYTKKQVLRME 128
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 129 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 182
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIA +A A + + E++IR+ T Y E L+ CL D
Sbjct: 183 YLPSVIAGAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 226
>pdb|1QMZ|B Chain B, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|D Chain D, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1H24|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|B Chain B, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|D Chain D, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|B Chain B, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|D Chain D, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2C5N|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2UUE|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|B Chain B, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|D Chain D, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2WMA|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|B Chain B, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|D Chain D, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 259
Score = 30.8 bits (68), Expect = 1.7, Method: Compositional matrix adjust.
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 16 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 75
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + + + ++E + E+ K Q++ ME
Sbjct: 76 ------LRGKLQLVGTAAMLL-------ASKFEEIYPPEVAEFVYITDDTYTKKQVLRME 122
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 123 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 176
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIA +A A + + E++IR+ T Y E L+ CL D
Sbjct: 177 YLPSVIAGAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 220
>pdb|1FIN|B Chain B, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|D Chain D, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1JSU|B Chain B, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FVV|B Chain B, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|D Chain D, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1OKV|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|B Chain B, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|D Chain D, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|B Chain B, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|D Chain D, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|B Chain B, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|D Chain D, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1URC|B Chain B, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|D Chain D, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|2C5O|B Chain B, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|D Chain D, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2CCH|B Chain B, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|D Chain D, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2I40|B Chain B, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|D Chain D, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|3EID|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|B Chain B, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|D Chain D, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|B Chain B, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|D Chain D, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2WEV|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 260
Score = 30.8 bits (68), Expect = 1.8, Method: Compositional matrix adjust.
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 17 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 76
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + ++ ++E + E+ K Q++ ME
Sbjct: 77 ------LRGKLQLVGTAAMLLAS-------KFEEIYPPEVAEFVYITDDTYTKKQVLRME 123
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 124 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 177
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIA +A A + + E++IR+ T Y E L+ CL D
Sbjct: 178 YLPSVIAGAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 221
>pdb|1JST|B Chain B, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|D Chain D, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1GY3|B Chain B, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|D Chain D, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1H1P|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1P5E|B Chain B, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|D Chain D, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1PKD|B Chain B, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|D Chain D, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|2C6T|B Chain B, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|D Chain D, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|B Chain B, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|D Chain D, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CCI|B Chain B, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|D Chain D, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2UZB|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|B Chain B, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|D Chain D, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4EOI|B Chain B, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|D Chain D, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOJ|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOK|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOM|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EON|B Chain B, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|D Chain D, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOO|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOP|B Chain B, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|D Chain D, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOQ|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOR|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOS|B Chain B, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|D Chain D, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 258
Score = 30.8 bits (68), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 15 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 74
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + ++ ++E + E+ K Q++ ME
Sbjct: 75 ------LRGKLQLVGTAAMLLAS-------KFEEIYPPEVAEFVYITDDTYTKKQVLRME 121
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 122 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 175
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIA +A A + + E++IR+ T Y E L+ CL D
Sbjct: 176 YLPSVIAGAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 219
>pdb|1OGU|B Chain B, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|D Chain D, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|B Chain B, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|D Chain D, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|2IW6|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW8|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW9|B Chain B, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|D Chain D, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 260
Score = 30.4 bits (67), Expect = 1.9, Method: Compositional matrix adjust.
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 17 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 76
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + + + ++E + E+ K Q++ ME
Sbjct: 77 ------LRGKLQLVGTAAMLL-------ASKFEEIYPPEVAEFVYITDDTYTKKQVLRME 123
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 124 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 177
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIA +A A + + E++IR+ T Y E L+ CL D
Sbjct: 178 YLPSVIAGAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 221
>pdb|1E9H|B Chain B, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|D Chain D, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
Length = 261
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 15 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 74
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + ++ ++E + E+ K Q++ ME
Sbjct: 75 ------LRGKLQLVGTAAMLLAS-------KFEEIYPPEVAEFVYITDDTYTKKQVLRME 121
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 122 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 175
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIA +A A + + E++IR+ T Y E L+ CL D
Sbjct: 176 YLPSVIAGAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 219
>pdb|2X1N|B Chain B, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|D Chain D, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
Length = 261
Score = 30.4 bits (67), Expect = 2.0, Method: Compositional matrix adjust.
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 18 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 77
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + ++ ++E + E+ K Q++ ME
Sbjct: 78 ------LRGKLQLVGTAAMLLAS-------KFEEIYPPEVAEFVYITDDTYTKKQVLRME 124
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 125 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 178
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIA +A A + + E++IR+ T Y E L+ CL D
Sbjct: 179 YLPSVIAGAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 222
>pdb|3F5X|B Chain B, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|D Chain D, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
Length = 256
Score = 30.4 bits (67), Expect = 2.1, Method: Compositional matrix adjust.
Identities = 47/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 13 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 72
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + + + ++E + E+ K Q++ ME
Sbjct: 73 ------LRGKLQLVGTAAMLL-------ASKFEEIYPPEVAEFVYITDDTYTKKQVLRME 119
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 120 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 173
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIA +A A + + E++IR+ T Y E L+ CL D
Sbjct: 174 YLPSVIAGAAFHLALYTVTGQSW---PESLIRK-TGYTLE-SLKPCLMD 217
>pdb|3EP5|A Chain A, Human Adometdc E178q Mutant With No Putrescine Bound
pdb|3EP8|A Chain A, Human Adometdc E178q Mutant Complexed With S-
Adenosylmethionine Methyl Ester And No Putrescine Bound
pdb|3EPA|A Chain A, Human Adometdc E178q Mutant Complexed With Putrescine
Length = 260
Score = 30.0 bits (66), Expect = 2.8, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD ++ L ++LD D + G T S R +P
Sbjct: 89 WYLYTLDFPESRVISQPDQTLQILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 148
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 149 VIDATMFNPCGYSMNGM 165
>pdb|1JL0|A Chain A, Structure Of A Human S-Adenosylmethionine Decarboxylase
Self-Processing Ester Intermediate And Mechanism Of
Putrescine Stimulation Of Processing As Revealed By The
H243a Mutant
pdb|1JL0|B Chain B, Structure Of A Human S-Adenosylmethionine Decarboxylase
Self-Processing Ester Intermediate And Mechanism Of
Putrescine Stimulation Of Processing As Revealed By The
H243a Mutant
Length = 334
Score = 30.0 bits (66), Expect = 2.9, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 157 WYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 216
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 217 VIDATMFNPCGYSMNGM 233
>pdb|2JGZ|B Chain B, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 260
Score = 30.0 bits (66), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 35/177 (19%), Positives = 70/177 (39%), Gaps = 16/177 (9%)
Query: 40 SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEVPRMLGGMREDIVLAADACLT 99
++R I + ++Q+ L Y ++I DRF+ N VP+ + +
Sbjct: 34 NMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNCVPKKMLQL------------- 80
Query: 100 ISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAMEQKIDVGVDWRMRVATPISFV 159
+ + + Y+E + ++ K Q+ ME KI +++ + P+ F+
Sbjct: 81 VGVTAMFIASKYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFL 140
Query: 160 EFFVXXXXXXXXXXXXTLNEIVIQ-TQGDISFTRFLPTVIAASAVFTACRVLFNDQY 215
TL + +++ T D F P+ IAA A A ++L N ++
Sbjct: 141 R--RASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFCLALKILDNGEW 195
>pdb|1MSV|A Chain A, The S68a S-adenosylmethionine Decarboxylase Proenzyme
Processing Mutant.
pdb|1MSV|B Chain B, The S68a S-adenosylmethionine Decarboxylase Proenzyme
Processing Mutant
Length = 354
Score = 30.0 bits (66), Expect = 3.1, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 157 WYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 216
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 217 VIDATMFNPCGYSMNGM 233
>pdb|1I72|A Chain A, Human S-Adenosylmethionine Decarboxylase With Covalently
Bound Pyruvoyl Group And Covalently Bound
5'-Deoxy-5'-[n-Methyl-N-(2- Aminooxyethyl)
Amino]adenosine
pdb|1I79|A Chain A, Human S-Adenosylmethionine Decarboxylase With Covalently
Bound Pyruvoyl Group And Covalently Bound
5'-Deoxy-5'-[(3-Hydrazinopropyl) Methylamino]adenosine
pdb|1I7B|A Chain A, Human S-Adenosylmethionine Decarboxylase With Covalently
Bound Pyruvoyl Group And Covalently Bound
S-Adenosylmethionine Methyl Ester
pdb|1I7C|A Chain A, Human S-Adenosylmethionine Decarboxylase With Covalently
Bound Pyruvoyl Group And Complexed With Methylglyoxal
Bis-(Guanylhydrazone)
Length = 267
Score = 29.6 bits (65), Expect = 3.3, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 90 WYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 149
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 150 VIDATMFNPCGYSMNGM 166
>pdb|3H0V|A Chain A, Human Adometdc With 5'-Deoxy-5'-(Dimethylsulfonio)
Adenosine
pdb|3H0W|A Chain A, Human Adometdc With 5'-Deoxy-5'-[(N-Dimethyl)amino]-8-
Methyl-Adenosine
Length = 266
Score = 29.6 bits (65), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 89 WYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 148
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 149 VIDATMFNPCGYSMNGM 165
>pdb|3DZ2|A Chain A, Human Adometdc With
5'-[(3-Aminopropyl)methylamino]-5'deoxy-
8-Methyladenosine
pdb|3DZ4|A Chain A, Human Adometdc With
5'-[(2-Carboxamidoethyl)methylamino]-5'-
Deoxy-8-Methyladenosine
pdb|3DZ5|A Chain A, Human Adometdc With Covalently Bound 5'-[(2-Aminooxyethyl)
Methylamino]-5'-Deoxy-8-Methyladenosine
pdb|3DZ6|A Chain A, Human Adometdc With 5'-[(4-Aminooxybutyl)methylamino]-
5'deoxy-8-Ethyladenosine
pdb|3DZ7|A Chain A, Human Adometdc With
5'-[(Carboxamidomethyl)methylamino]-5'-
Deoxy-8-Methyladenosine
Length = 267
Score = 29.6 bits (65), Expect = 3.4, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 90 WYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 149
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 150 VIDATMFNPCGYSMNGM 166
>pdb|1JEN|A Chain A, Human S-Adenosylmethionine Decarboxylase
pdb|1JEN|C Chain C, Human S-Adenosylmethionine Decarboxylase
Length = 267
Score = 29.6 bits (65), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 90 WYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 149
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 150 VIDATMFNPCGYSMNGM 166
>pdb|2B9R|A Chain A, Crystal Structure Of Human Cyclin B1
pdb|2B9R|B Chain B, Crystal Structure Of Human Cyclin B1
Length = 269
Score = 29.6 bits (65), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 37/177 (20%), Positives = 71/177 (40%), Gaps = 16/177 (9%)
Query: 40 SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEVPRMLGGMREDIVLAADACLT 99
++R I + ++Q+ L Y ++I DRF+ N VP+ + + L +
Sbjct: 36 NMRAILIDWLVQVQMKFRLLQETMYMTVSIIDRFMQNNSVPKKM------LQLVGVTAMF 89
Query: 100 ISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAMEQKIDVGVDWRMRVATPISFV 159
I+ Y+E + ++ K Q+ ME KI +++ + P+ F+
Sbjct: 90 IAS-------KYEEMYPPEIGDFAFVTDNTYTKHQIRQMEMKILRALNFGLGRPLPLHFL 142
Query: 160 EFFVXXXXXXXXXXXXTLNEIVIQ-TQGDISFTRFLPTVIAASAVFTACRVLFNDQY 215
TL + +++ T D F P+ IAA A A ++L N ++
Sbjct: 143 R--RASKIGEVDVEQHTLAKYLMELTMLDYDMVHFPPSQIAAGAFSLALKILDNGEW 197
>pdb|3EP4|A Chain A, Human Adometdc E256q Mutant With No Putrescine Bound
pdb|3EP7|A Chain A, Human Adometdc E256q Mutant Complexed With S-
Adenosylmethionine Methyl Ester And No Putrescine Bound
pdb|3EPB|A Chain A, Human Adometdc E256q Mutant Complexed With Putrescine
Length = 260
Score = 29.3 bits (64), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 89 WYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 148
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 149 VIDATMFNPCGYSMNGM 165
>pdb|3EP9|A Chain A, Human Adometdc With No Putrescine Bound
Length = 260
Score = 29.3 bits (64), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 22/77 (28%), Positives = 34/77 (44%), Gaps = 6/77 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 89 WYLYTLDFPESRVISQPDQTLEILMSELDPAVMDQFYMKDGVTAKDVTRESGIRDLIPGS 148
Query: 362 IAAPTLFTACRYLYNGL 378
+ T+F C Y NG+
Sbjct: 149 VIDATMFNPCGYSMNGM 165
>pdb|4BCQ|B Chain B, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 262
Score = 28.9 bits (63), Expect = 6.3, Method: Compositional matrix adjust.
Identities = 46/229 (20%), Positives = 94/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 19 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + ++ ++E + E+ K Q++ ME
Sbjct: 79 ------LRGKLQLVGTAAMLLAS-------KFEEIYPPEVAEFVYITDDTYTKKQVLRME 125
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 126 HLVLKVLTFDLAAPTVNQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 179
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIAA+A A + + E++IR+ T Y E + C+ D
Sbjct: 180 YLPSVIAAAAFHLALYTVTGQSW---PESLIRK-TGYTLETS-KPCMLD 223
>pdb|2W96|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W99|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9F|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 271
Score = 28.5 bits (62), Expect = 7.3, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 53/124 (42%), Gaps = 13/124 (10%)
Query: 40 SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEVPRMLGGMREDIVLAADACLT 99
S+RKI +L++ + + + AMN DRF+S V + + L C+
Sbjct: 55 SMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPVK------KSRLQLLGATCMF 108
Query: 100 ISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAMEQKIDVGVDWRMRVATPISFV 159
++ +K T E L Y D +R +L+ ME + + W + TP F+
Sbjct: 109 VASKMKETIPLTAEKLCI----YTDNS---IRPEELLQMELLLVNKLKWNLAAMTPHDFI 161
Query: 160 EFFV 163
E F+
Sbjct: 162 EHFL 165
>pdb|1I7M|A Chain A, Human S-Adenosylmethionine Decarboxylase With Covalently
Bound Pyruvoyl Group And Complexed With
4-Amidinoindan-1-One-2'- Amidinohydrazone
pdb|1I7M|C Chain C, Human S-Adenosylmethionine Decarboxylase With Covalently
Bound Pyruvoyl Group And Complexed With
4-Amidinoindan-1-One-2'- Amidinohydrazone
Length = 267
Score = 28.5 bits (62), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 22/76 (28%), Positives = 32/76 (42%), Gaps = 6/76 (7%)
Query: 308 WMMLSSEDPEERTINFPD--IRTLATDLDDPSDDN---RAGATTFRELHISSTR-CLPTV 361
W + + + PE R I+ PD + L ++LD D + G T S R +P
Sbjct: 90 WYLYTLDFPESRVISQPDQTLEILXSELDPAVXDQFYXKDGVTAKDVTRESGIRDLIPGS 149
Query: 362 IAAPTLFTACRYLYNG 377
+ T F C Y NG
Sbjct: 150 VIDATXFNPCGYSXNG 165
>pdb|2G9X|B Chain B, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|D Chain D, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
Length = 262
Score = 28.5 bits (62), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 46/229 (20%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 19 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + ++ ++E + E+ K Q++ ME
Sbjct: 79 ------LRGKLQLVGTAAMLLASK-------FEEIYPPEVAEFVYITDDTYTKKQVLRME 125
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 126 HLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 179
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIAA+A A + + E+++++ T Y E L+ CL D
Sbjct: 180 YLPSVIAAAAFHLALYTVTGQSW---PESLVQK-TGYTLET-LKPCLLD 223
>pdb|1VIN|A Chain A, Bovine Cyclin A3
Length = 268
Score = 28.5 bits (62), Expect = 9.0, Method: Compositional matrix adjust.
Identities = 46/229 (20%), Positives = 95/229 (41%), Gaps = 34/229 (14%)
Query: 23 IEMHWMPAEGYAESNKE---SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEV 79
+E+ P GY + + S+R I + ++++ + L + A+N DRF+S V
Sbjct: 19 MEVKCKPKVGYMKKQPDITNSMRAILVDWLVEVGEEYKLQNETLHLAVNYIDRFLSSMSV 78
Query: 80 PRMLGGMREDIVLAADACLTISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAME 139
+R + L A + ++ ++E + E+ K Q++ ME
Sbjct: 79 ------LRGKLQLVGTAAMLLASK-------FEEIYPPEVAEFVYITDDTYTKKQVLRME 125
Query: 140 QKIDVGVDWRMRVATPISFV-EFFVXXXXXXXXXXXXTLNEIVIQTQGDIS------FTR 192
+ + + + T F+ ++F+ E + G++S + +
Sbjct: 126 HLVLKVLAFDLAAPTINQFLTQYFLHQQPANCKV------ESLAMFLGELSLIDADPYLK 179
Query: 193 FLPTVIAASAVFTACRVLFNDQYYREKENMIRRVTKYVDEVDLEACLED 241
+LP+VIAA+A A + + E+++++ T Y E L+ CL D
Sbjct: 180 YLPSVIAAAAFHLALYTVTGQSW---PESLVQK-TGYTLET-LKPCLLD 223
>pdb|2W9Z|A Chain A, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 257
Score = 28.1 bits (61), Expect = 9.5, Method: Compositional matrix adjust.
Identities = 31/124 (25%), Positives = 53/124 (42%), Gaps = 13/124 (10%)
Query: 40 SLRKIAMHQILQISKSNNLDAMIPYAAMNIFDRFISRNEVPRMLGGMREDIVLAADACLT 99
S+RKI +L++ + + + AMN DRF+S V + + L C+
Sbjct: 41 SMRKIVATWMLEVCEEQKCEEEVFPLAMNYLDRFLSLEPV------KKSRLQLLGATCMF 94
Query: 100 ISWSVKSTSFSYDEFLEADNHEYKDTDARVVRKVQLVAMEQKIDVGVDWRMRVATPISFV 159
++ +K T E L Y D +R +L+ ME + + W + TP F+
Sbjct: 95 VASKMKETIPLTAEKLCI----YTDNS---IRPEELLQMELLLVNKLKWNLAAMTPHDFI 147
Query: 160 EFFV 163
E F+
Sbjct: 148 EHFL 151
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.320 0.135 0.400
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 12,470,223
Number of Sequences: 62578
Number of extensions: 475879
Number of successful extensions: 876
Number of sequences better than 100.0: 32
Number of HSP's better than 100.0 without gapping: 0
Number of HSP's successfully gapped in prelim test: 32
Number of HSP's that attempted gapping in prelim test: 861
Number of HSP's gapped (non-prelim): 38
length of query: 455
length of database: 14,973,337
effective HSP length: 102
effective length of query: 353
effective length of database: 8,590,381
effective search space: 3032404493
effective search space used: 3032404493
T: 11
A: 40
X1: 16 ( 7.4 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.8 bits)
S2: 53 (25.0 bits)